Danimer Scientific Announces Intention to Complete a Reverse Stock Split
BAINBRIDGE, Ga., November 01, 2024--Danimer Scientific, Inc. (NYSE: DNMR) ("Danimer" or "Company"), a leading, next-generation biotechnology company focused on the production of biomaterials, announced today that, following approval by the Company’s stockholders and its Board of Directors, the Company will effect a reverse stock split ("Reverse Stock Split") of Danimer’s Class A common stock, par value $0.0001 per share ("Common Stock"), at a ratio of 1-for-40 (the "Reverse Stock Split Ratio"),